Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Wheeler

Showing results (51-60 of 453) with videos related to

Pageof 46
Sort By:
The New England Journal of Medicine|January 27, 2021
Dapagliflozin in Patients with Chronic Kidney Disease. ReplyHiddo J L Heerspink, Anna-Maria Langkilde, David C Wheeler
The Science of the Total Environment|January 25, 2021
Modeling elevated blood lead level risk across the United StatesDavid C Wheeler, Joseph Boyle, Shyam Raman, et al.
International Journal of Environmental Research and Public Health|February 15, 2022
Imputation of Below Detection Limit Missing Data in Chemical Mixture Analysis with Bayesian Group Index RegressionMatthew Carli, Mary H Ward, Catherine Metayer, et al.
Spatial and Spatio-Temporal Epidemiology|January 29, 2021
A Bayesian approach to improving spatial estimates of prevalence of COVID-19 after accounting for misclassification bias in surveillance data in Philadelphia, PANeal D Goldstein, David C Wheeler, Paul Gustafson, et al.
Kidney International|March 29, 2002
A placebo-controlled trial examining atorvastatin in dyslipidemic patients undergoing CAPDKevin P G Harris, David C Wheeler, Camilla C Chong, et al.
The Science of the Total Environment|October 13, 2018
Explaining variation in elevated blood lead levels among children in Minnesota using neighborhood socioeconomic variablesDavid C Wheeler, Resa M Jones, Mario Schootman, et al.
BMC Cancer|April 23, 2011
Applying strategies from libertarian paternalism to decision making for prostate specific antigen (PSA) screeningDavid C Wheeler, Konrad M Szymanski, Amanda Black, et al.
Spatial and Spatio-Temporal Epidemiology|June 12, 2012
Spatial-temporal analysis of non-Hodgkin lymphoma risk using multiple residential locationsDavid C Wheeler, Lance A Waller, Wendy Cozen, et al.
The Lancet. Diabetes & Endocrinology|December 24, 2018
New pharmacological strategies for protecting kidney function in type 2 diabetesMarcel H A Muskiet, David C Wheeler, Hiddo J L Heerspink
Plos One|June 26, 2015
Geographic analysis of urologist density and prostate cancer mortality in the United StatesNengliang Yao, Steven M Foltz, Anobel Y Odisho, et al.
Pageof 46

Showing results (51-60 of 453) with videos related to

Sort By:
Pageof 46
The New England Journal of Medicine|January 27, 2021
Dapagliflozin in Patients with Chronic Kidney Disease. ReplyHiddo J L Heerspink, Anna-Maria Langkilde, David C Wheeler
The Science of the Total Environment|January 25, 2021
Modeling elevated blood lead level risk across the United StatesDavid C Wheeler, Joseph Boyle, Shyam Raman, et al.
International Journal of Environmental Research and Public Health|February 15, 2022
Imputation of Below Detection Limit Missing Data in Chemical Mixture Analysis with Bayesian Group Index RegressionMatthew Carli, Mary H Ward, Catherine Metayer, et al.
Spatial and Spatio-Temporal Epidemiology|January 29, 2021
A Bayesian approach to improving spatial estimates of prevalence of COVID-19 after accounting for misclassification bias in surveillance data in Philadelphia, PANeal D Goldstein, David C Wheeler, Paul Gustafson, et al.
Kidney International|March 29, 2002
A placebo-controlled trial examining atorvastatin in dyslipidemic patients undergoing CAPDKevin P G Harris, David C Wheeler, Camilla C Chong, et al.
The Science of the Total Environment|October 13, 2018
Explaining variation in elevated blood lead levels among children in Minnesota using neighborhood socioeconomic variablesDavid C Wheeler, Resa M Jones, Mario Schootman, et al.
BMC Cancer|April 23, 2011
Applying strategies from libertarian paternalism to decision making for prostate specific antigen (PSA) screeningDavid C Wheeler, Konrad M Szymanski, Amanda Black, et al.
Spatial and Spatio-Temporal Epidemiology|June 12, 2012
Spatial-temporal analysis of non-Hodgkin lymphoma risk using multiple residential locationsDavid C Wheeler, Lance A Waller, Wendy Cozen, et al.
The Lancet. Diabetes & Endocrinology|December 24, 2018
New pharmacological strategies for protecting kidney function in type 2 diabetesMarcel H A Muskiet, David C Wheeler, Hiddo J L Heerspink
Plos One|June 26, 2015
Geographic analysis of urologist density and prostate cancer mortality in the United StatesNengliang Yao, Steven M Foltz, Anobel Y Odisho, et al.
Pageof 46